Antimicrobial peptide NK-lysin

General Information


DRACP ID  DRACP01075

Peptide Name   Antimicrobial peptide NK-lysin

Sequence  GYFCESCRKIIQKLEDMVGPQPNEDTVTQAASQVCDKLKILRGLCKKIMRSFLRRISWDILTGKKPQAICVDIKICKE

Sequence Length  78

UniProt ID  Not available

PubChem CID  Not available

Origin  Sus scrofa

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
YAC-1 Mouse lymphoma Lymphoma LC90=50 µg/ml Esuspension of the cell lines in 1% Nonidet P-40 2h 1

Hemolytic Activity  Sheep erythrocytes: 0% Hemolysis=170 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01075

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys4<--->Cys76; Cys7<--->Cys70; Cys35<--->Cys45

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C391H656N110O111S8

Absent amino acids  H

Common amino acids  KI

Mass  1030433

Pl  9.15

Basic residues  15

Acidic residues  9

Hydrophobic residues  25

Net charge  6

Boman Index  -13691

Hydrophobicity  -23.08

Aliphatic Index  93.72

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  7365

Absorbance 280nm  95.65

Polar residues  19

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 7737114

Title  NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity

Doi NA

Year  1995

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.